The Amgen headquarters in Thousand Oaks, Calif. (AP/Mark J. Terrill)

Supreme Court Deals Blow To Big Pharma Over Little-Known ACA Provision

The case hinged on a little-known aspect of the Affordable Care Act that would expedite the release of generic drugs, a provision contested by major pharmaceuticals firms.